Target Group Inc. (OTCQB: CBDY) Breakout Alert $.10 Target

New Report just released on EmergingGrowth.com

https://emerginggrowth.com/target-group-inc-otcqb-cbdy-finding-value-in-the-cannabis-sector/

Awarded 3 Licenses from health Canada to Cultivate, Process and Sell Cannabis

Completed $20 million Raise

Miami, FL--(InvestorsHub NewsWire – November 19, 2019) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Target Group, Inc. (OTCQB: CBDY).

This could be the biggest play in the Cannabis space in years. See the full story on http://www.EmergingGrowth.com

CBDY may not be at these levels much longer.

See the Press Release and more on Target Group, Inc. (OTCQB: CBDY) at EmergingGrowth.com

https://emerginggrowth.com/stock-report/?code=cbdy

Target Group, Inc. (OTCQB: CBDY) is displaying value in the Cannabis sector.

Target Group (OTCQB: CBDY) is a progressive, diversified, and vertically integrated cannabis investment company who is expanding their global operations to build an international network of manufacturing, distribution, production, and sales. Target Group is creating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability.

Target Group (OTCQB: CBDY) was listed on the OTCQB in late 2017 and by August 2018, the company completed its first wholly owned acquisition of CanaryRX, a licensed producer pursuant to the Cannabis Act (Bill C-45) (http://www.CanaryRX.com).

By June of 2018, the company had completed $20 million in equity financing in order to complete the buildout of its Norfolk County cultivation facility.

Target Group (OTCQB: CBDY) is vertically integrated in all aspects of the cannabis market.

Target Group, Inc. (OTCQB: CBDY) has also completed a number of acquisitions.

Canary:

Canary, its first acquisition consists of a state of the art, 44,000 sq. ft, $13 million Norfolk County premium growth production facility. Each of the 8 isolated grow rooms will produce ultra-premium, small batch and artisanal cannabis amounting to $3.6 million grams annually.

The company received its cultivation, processing and sales license in October 2019, and will begin to grow and produce, CBD and THC products (where permitted by law) based on unique premium genetics. Its massive indoor climate-controlled facility allows for growing year-round.

In addition to cultivation, Canary will additionally focus its efforts on a joint venture relating to co-packing & Co-manufacturing services with a multinational partner allowing it to not only be vertically integrated in its value chain, but also will enable Canary through this JV to create white label products for all other Licensed producers.

Serious Seeds:

Having a well-known brand behind you is the key to standing out in a market with more newcomers coming in daily.

Serious Seeds (http://www.SeriousSeeds.com) has been an established brand, offering the best quality of cannabis strains in the market since 1994, and is now under the umbrella of Target Group, Inc. (OTCQB: CBDY).

Canary RX has signed a partnership agreement whereby it is effectively the world manufacturer and distributor of Serious Seeds products in all legal markets.

Serious Seeds, having won more than 100 awards is the home of the classic award-winning cannabis strains AK-47, Bubble Gum, Chronic, Kali Mist, White Russian, Warlock, Double Dutch, Biddy Early, Motavation, Serious 6, Autoflowering White Russian #1, Serious Happiness, Serious Kush, CBD-Chronic, CBD-enriched Warlock and Strawberry-AKeil.

Serious seeds will be exclusively supplying premium seeds to Canary's state of the art facility.

CANABC:

Experts in the industry, see the cannabis startup failure rate to exceed 97%. The main reasons behind this, is that with most cannabis companies, the do not allocate resources for guidance in avoiding the pitfalls that inevitably arrive.

In order to not become a statistic, Target Group, Inc. (OTCQB: CBDY) entered into an agreement with cannabis consulting firm CANABC.

With micro-licensing as a specialty, CANABC offers full-spectrum consulting services to assist cannabis entrepreneurs in obtaining a micro cultivation, processing or nursery license from health Canada. (https://www.canada.ca/en/services/health.html). From Seed to Sale, CANABC guides and supports clients to get licensed and stay licensed.

Their services include:

Business Plan & Networking
Site Suitability Assessment
Assistance with CTLS Application
Custom Quality Assurance & Security Program, SOPs & GPPs
Pre-Licensing & Approval Process Support
Premium Genetics, Brand Partnerships, Marketing
Sales & Distribution through their partner, Canary RX
Ongoing Operational and Compliance Support
Testing, Retention & Recalls
Qualified Consultant Recommendations

Since 2017, CANABC has also helped over 8,000 patients who were interested in exploring cannabis as a treatment option, obtain licenses from Health Canada CANABC provides prescription services, or helps individuals register to produce cannabis for their own medical use.

Target Group, Inc. (OTCQB: CBDY) will receive a not only a consulting fee (based on size location and production) for CANABC's services, but also the first right of refusal on the cultivated product of those who it consults for allowing for "Flexible Production" without any increase in production space.

CANABC is a diamond in the rough for not only those new to the space, but more so to Target Group, Inc. (OTCQB: CBDY), as it is the quality control, making sure that seeds are up to highest standards.

CannaKorp, (http://www.CannaKorp.com another Target Group, Inc. (OTCQB: CBDY) acquisition, is the brainchild of one of the ex-executives of Keurig, Inc. (NYSE: KDP)

CannaKorp raised $6 million on their own and currently holds a design patent for pods for their flagship vaporizer "Wisp" with other international patents currently in review.

Similar to a Keurig coffee machine, Wisp is a flower based vaporizing system that takes "pods" which contain CBD or THC flower (where permitted by law) in natural botanical and herbal form that, through the pods are converted into vapor form free of combustion, additives, and without denaturing.

Target Group's (OTCQB: CBDY) wholly owned subsidiary Canary will perform the co-packing of the Wisp pods for all of its partners in Canada to offer an easy and centralized turnkey solution for pod production.

Like Keurig, third party partners will be able to create their own pods by sending their bulk flower for processing with a variety of botanical and herbal flavors of which Target Group (OTCQB: CBDY) through CannaKorp will receive a royalty.

CannaKorp's offices are located in the US in Boston Massachusetts.

CannaKorp and its Wisp vaporizer opens Target Group (OTCQB: CBDY) to a possible acquisition by a major. Not 12 months ago, vaporizer company Volcano was acquired by Canopy Growth (NYSE: CGC) for approximately $160 million.

To complete Target Group's (OTCQB: CBDY) circle, in lies TrueFocus. Currently Target Group has the exclusive licensing rights for Europe, UK, the USA and the Caribbean.

True Focus, a future acquisition planed by Target Group (OTCQB: CBDY) is an oral spray that counteracts negative effects of CBD / THC such as anxiety, "couch lock", and grogginess and influences a more levelheaded feeling.

This goes very far as a medical application to counter act the negative side effects of potent forms of cannabinoids such as concentrates and edibles among others. A few simple sprays under the tongue will yield a more positive outlook and allow more patients to be able to benefit from this route.

Investment Summary

The cannabis sector clearly looks like it has put in a double bottom on a technical basis so now could be an opportune time to step into the sector and buy value with a foundation. The next stage of growth could very well be mergers and acquisitions, but it's unlikely that the top brands backed by conglomerates will be creating mega brands. Those businesses like TLRY, CRON, and CGC will start to work when these large brands start selling and launching CBD or THC infused products.

Mergers an acquisition plays could also begin to happen in the space and represent big upside for investors. The sweet spot in the sectors seems to be a company that has a modest valuation, that spans full circle in the space, and could also be an acquisition target. CBDY possesses all of these characteristics. By all metrics the stock seems extremely undervalued and ready to run.

The risk in this situation is the company's ability to generate funds to take them from their initial growth through a couple seasons of sales. The company, however, did already demonstrate their ability to close a $20 million raise in June of 2018.

Baring financing, we see huge potential for the stock which could be trading over the .10 mark once we see consistent revenue begin to pour in.

CBDY may not be at these levels much longer.

See the Press Release and more on Target Group, Inc. (OTCQB: CBDY) at EmergingGrowth.com

https://emerginggrowth.com/stock-report/?code=cbdy

About EmergingGrowth.com

EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies. Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization. We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth. Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community. Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information includes certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks. This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. EmergingGrowth.com has been compensated fifteen thousand dollars in consideration for its work with Target Group, Inc. through the date this was published. EmergingGrowth.com may or may not receive additional compensation, details about which can be found in our full disclosure, which can be found here, https://emerginggrowth.com/2239-68272/ . You can easily loose money investing in highly speculative small cap stocks like the ones mentioned within. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.